Charles Elliott Sigal
Director · Vir Biotechnology, Inc.
Individual
- 2025
- May 28, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles Elliott Sigal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Yvonne Greenstreet - $16.95M in ALNY purchases and sales in the last 12 months
- SVF Endurance (Cayman) Ltd - $9.98M in VIR purchases and sales in the last 12 months
- Kevin Joseph Fitzgerald - $8.24M in ALNY purchases and sales in the last 12 months
- Pushkal Garg - $4.88M in ALNY purchases and sales in the last 12 months
- Jeffrey V. Poulton - $2.22M in ALNY purchases and sales in the last 12 months
- Tolga Tanguler - $1.88M in ALNY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles Elliott Sigal?
Charles Elliott Sigal is a corporate insider, tracked as Director of Vir Biotechnology, Inc. (VIR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Charles Elliott Sigal last file a Form 4?
The most recent primary Form 4 on record is dated 28 May 2026, one of 3 filings going back to 2025.
